Biomea Fusion (BMEA) Current Leases (2020 - 2026)
Biomea Fusion (BMEA) posted Current Leases of $1.2 million for Q1 2026, down 15.2% sequentially from $1.5 million in Q4 2025, and down 13.11% YoY from $1.4 million in Q1 2025.
Biomea Fusion (BMEA) Current Leases (2020 - 2026) Analysis & Trends
Biomea Fusion has reported Current Leases for 7 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Current Leases fell 13.11% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 13.11% YoY) and the FY2025 annual result came in at $1.5 million, down 29.73% from the prior year.
- Current Leases slipped to $1.2 million in Q1 2026 per BMEA's latest filing, from $1.5 million in the prior quarter.
- Over five years, Current Leases peaked at $3.3 million in Q2 2024 and troughed at $578000.0 in Q1 2022.
- A 5-year average of $1.8 million and a median of $1.5 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases surged 366.94% in 2023, then tumbled 77.04% in 2025.
- Over 5 years, Current Leases stood at $618000.0 in 2022, then surged by 299.03% to $2.5 million in 2023, then retreated by 15.69% to $2.1 million in 2024, then declined by 29.73% to $1.5 million in 2025, then slipped by 15.2% to $1.2 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.2 million, $1.5 million, and $787000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - | 877,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 877,000.00 |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 787,000.00 |
| Jun 30, 2025 | 755,000.00 |
| Mar 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | 3.29 Mn |
| Mar 31, 2024 | 3.17 Mn |
| Dec 31, 2023 | 2.47 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 2.61 Mn |
| Dec 31, 2022 | 618,000.00 |
| Sep 30, 2022 | 605,000.00 |
| Jun 30, 2022 | 591,000.00 |
| Mar 31, 2022 | 578,000.00 |
| Dec 31, 2021 | 565,000.00 |
| Sep 30, 2021 | 554,000.00 |